Weight

The world has launched into an era of injectables not just to treat obesity but to manage weight. Is that all good news?

Studies of goal setting reveal why it’s so hard to keep resolutions—and how to make ones that actually stick

Ozempic and similar drugs are ushering in a new era of weight management and obesity treatments, and researchers are racing to understand their impact

From new uses for weight-loss drugs to the first CRISPR gene editing therapy, these were some of the most impactful health stories of the year

The active ingredient in Wegovy and Ozempic reduced the risk of heart attacks and strokes in a large trial of people with cardiovascular disease who were considered overweight or had obesity, but the cost and side effects remain barriers

Laxative misuse is cropping up in wellness and weight-loss social media communities—and some experts are concerned about its close ties to eating disorders

Recent studies evaluate risks associated with drugs such as Wegovy and Mounjaro

Insurance plans could cover blockbuster weight-loss medications such as Wegovy and Ozempic, but the benefits may not be accessible to everyone

The new social media trend “budget Ozempic” promotes laxatives and stool softeners for weight loss, but these drugs are dangerous if misused

Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashed risk of heart attacks and other cardiovascular incidents in a trial

Limited data on adults age 60 and older raise questions on whether high-priced weight-loss drugs will really help with lowering rates of chronic illness and disability

United Nations groups say the artificial sweetener poses a possible risk of liver cancer—but there’s no evidence for harm under the current daily limit